Cargando…
Risks in Induction of Platelet Aggregation and Enhanced Blood Clot Formation in Platelet Lysate Therapy: A Pilot Study
Platelet concentrates (PCs) are widely used in regenerative medicine; as it is produced from freeze–thawing PC, platelet lysate (PL) has a longer shelf life. The thrombotic risk of PL therapy needs to be explored since PL and PC contain cytokines that contribute to platelet aggregation and thrombus...
Autores principales: | Wen, Ying-Hao, Lee, Chen-Fang, Chen, Yu-Ju, Chang, Gwo-Jyh, Chong, Kowit-Yu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9315595/ https://www.ncbi.nlm.nih.gov/pubmed/35887736 http://dx.doi.org/10.3390/jcm11143972 |
Ejemplares similares
-
Cytokines in equine platelet lysate and related blood products
por: Moellerberndt, Julia, et al.
Publicado: (2023) -
Influence of platelet storage time on human platelet lysates and platelet lysate-expanded mesenchymal stromal cells for bone tissue engineering
por: Shanbhag, Siddharth, et al.
Publicado: (2020) -
Identification of a novel platelet antagonist that binds to CLEC-2 and suppresses podoplanin-induced platelet aggregation and cancer metastasis
por: Chang, Yao-Wen, et al.
Publicado: (2015) -
Integrating platelet and coagulation activation in fibrin clot formation
por: Swieringa, Frauke, et al.
Publicado: (2018) -
Intragastric Application of Aspirin, Clopidogrel, Cilostazol, and BPC 157 in Rats: Platelet Aggregation and Blood Clot
por: Konosic, Sanja, et al.
Publicado: (2019)